Cite
HARVARD Citation
Deerochanawong, C. et al. (2019). Use of sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations. Diabetes, obesity & metabolism. 21 (11), pp. 2354-2367. [Online].